MedPath

四川百利药业有限责任公司

Ownership
-
Established
1996-08-23
Employees
-
Market Cap
-
Website
http://www.baili-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Guanfacine Hydrochloride Sustained-release Tablets

Product Name
盐酸胍法辛缓释片
Approval Number
国药准字H20253442
Approval Date
Feb 20, 2025
NMPA

Guanfacine Hydrochloride Sustained-release Tablets

Product Name
盐酸胍法辛缓释片
Approval Number
国药准字H20253443
Approval Date
Feb 20, 2025
NMPA

Gemcitabine Hydrochloride for Injection

Product Name
注射用盐酸吉西他滨
Approval Number
国药准字H20253258
Approval Date
Jan 24, 2025
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20253303
Approval Date
Jan 24, 2025
NMPA

Carboplatin Injection

Product Name
卡铂注射液
Approval Number
国药准字H20249713
Approval Date
Dec 6, 2024
NMPA

Cytarabine for Injection

Product Name
注射用阿糖胞苷
Approval Number
国药准字H20249109
Approval Date
Oct 22, 2024
NMPA

Levofolinate Calcium for Injection

Product Name
注射用左亚叶酸钙
Approval Number
国药准字H20249170
Approval Date
Oct 22, 2024
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20244980
Approval Date
Sep 26, 2024
NMPA

Azithromycin for Suspension

Product Name
阿奇霉素干混悬剂
Approval Number
国药准字H20244232
Approval Date
Jun 28, 2024
NMPA

Paracetamol,Anantadine Hydrochloride,Artificid Com-bezar and Chlorphenamine Mdeate Granules

Product Name
氨金黄敏颗粒
Approval Number
国药准字H20094092
Approval Date
Jun 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.